Biological rationale for a patient-specific approach in the treatment of breast cancer. Clinical value of novel biomarkers of breast cancer by R. M. Paltuev

Get full text

Biological rationale for patient-specific treatment of breast cancer. Analysis of new data for breast cancer by R. M. Paltuev

Get full text

Cancer patients with chronic pain syndrome: can we improve their quality of life? by M. M. Konstantinova, R. M. Paltuev

Get full text

Nausea and vomiting induced by pharmacotherapy: have all issues of maintenance therapy been resolved? by M.  M.  Konstantinova, R.  M.  Paltuev

Get full text

General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16^thth International Breast Cancer Conference) by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov

Get full text

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary by A. G. Manikhas, R. N. Babeshkin, R. M. Paltuev, G. M. Manikhas

Get full text

AUTOMATED ANALYSIS OF CELL DENSITY IN BREAST CANCER AS AN ADDITIONAL METHOD OF INCREASING OBJECTIVITY AND ACCURACY OF BREAST CANCER PROGNOSIS by R. M. Paltuev, A. G. Kudabergenova, V. F. Semiglazov, A. V. Komyakhov

Get full text

Prognostic value of FOXA1 in patients with Т1–2N0M0 breast cancer by R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. V. Komyakhov, A. I. Tseluyko

Get full text

Prognostic value of CD4⁺ in patients with Т1–2N0M0 breast cancer by R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. V. Komyakhov, A. I. Tseluyko

Get full text

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

Get full text

Prognostic and predictive value of a novel 100-point scale in patients with T1–2N0M0 breast cancer by R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova

Get full text

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe... by E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov

Get full text

New prospects in the use of Kadcyla® in breast cancer by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, R. M. Paltuev, E. E. Topuzov, T. Yu. Semiglazova, E. K. Zhil’tsova, R. V. Donskikh, T. T. Tabagua, V. S. Apollonova

Get full text

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases by T.  Yu.  Semiglazova, S.  M.  Sharashenidze, S.  N.  Kerimova, V.   V. Klimenko, A. Yu.  Malygin, G.  A.  Dashyan, R.   M. Paltuev, V.  V.  Semiglazov, P.   V. Krivorotko, S.  N.  Novikov, V.   F. Semiglazov

Get full text

Neoadjuvant treatment for breast cancer by V. F. Semiglazov, V. V. Semiglazov, R. M. Paltuev, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, A. V. Komyakhov, Zh. V. Bryantseva, K. S. Nikolaev, D. Ye. Shchedrin, A. M. Yermochenkova

Get full text

Results of research work Russian society of oncomammologists “The use of artificial intelligence for early detection of breast cancer” by V. I. Pavlova, Yu. A. Belaya, A. Yu. Vorontsov, A. A. Prishchepov, S. M. Knyazev, A. A. Mikhaylov, A. V. Kovaleva, E. G. Arevshatyan, R. M. Paltuev, A. V. Chernaya, N. A. Zakharova

Get full text

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases by G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova

Get full text

The role of local and systemic control methods in the treatment of oligometastatic breast cancer, taking into account biological subtypes (literature review) by T. I. Sevostyanova, T. Yu. Semiglazova, O. I. Ponasenko, V. A. Lyaschenko, Sh. R. Abdullaeva, L. V. Filatova, Zh. V. Bryantseva, B. S. Kasparov, R. M. Paltuev, V. V. Semiglazov, P. V. Krivorotko, S. N. Novikov, V. F. Semiglazov

Get full text

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER by V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov

Get full text

Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade by V. F. Semiglazov, N. B. Bekkeldieva, P. V. Krivorotko, A. V. Komyakhov, R. M. Paltuev, A. I. Tseluyko, L. P. Gigolaeva, T. T. Tabagua, E. K. Zhiltsova, V. S. Apollonova, G. A. Dashyan, A. G. Kudaybergenova, V. G. Ivanov, A. A. Bozhok, D. G. Ulrikh, A. O. Gorina, T. Yu. Semiglazova

Get full text